APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Galectin 3

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Galectin 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173993900322 December 2025186 pages

Choose your research edition.

Industry ResearchGalectin 3 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Galectin 3 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Galectin 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galectin 3 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Galectin 3 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Galectin 3 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Galectin 3 include MandalMed Inc, iTeos Therapeutics SA, GlycoMimetics Inc, Galectin Therapeutics Inc, Bristol-Myers Squibb Company and Angion Biomedica Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Galectin 3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Galectin 3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Galectin 3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Galectin 3 market size, projected growth trends, production technologies, key applications, and end-use industries.

Galectin 3 Segment by Company

MandalMed Inc

iTeos Therapeutics SA

GlycoMimetics Inc

Galectin Therapeutics Inc

Bristol-Myers Squibb Company

Angion Biomedica Corp

Galectin 3 Segment by Type

KTI

GRMD-03

GAL-300

ANG-4021

Others

Galectin 3 Segment by Application

Metastatic Melanoma

Portal Hypertension

Liver Cirrhosis

Others

Galectin 3 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galectin 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galectin 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galectin 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Galectin 3 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Galectin 3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Galectin 3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Galectin 3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Galectin 3 Industry Trends Table 2. Galectin 3 Industry Drivers Table 3. Galectin 3 Industry Opportunities and Challenges Table 4. Galectin 3 Industry Restraints Table 5. Global Galectin 3 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Galectin 3 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Galectin 3 Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Galectin 3 Sales Market Share by Manufacturers Table 9. Global Galectin 3 Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Galectin 3 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Galectin 3 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Galectin 3 Manufacturers, Product Type & Application Table 13. Global Galectin 3 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Galectin 3 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of KTI Table 17. Major Manufacturers of GRMD-03 Table 18. Major Manufacturers of GAL-300 Table 19. Major Manufacturers of ANG-4021 Table 20. Major Manufacturers of Others Table 21. Global Galectin 3 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Galectin 3 Sales by Type (2021-2026) & (k units) Table 23. Global Galectin 3 Sales by Type (2027-2032) & (k units) Table 24. Global Galectin 3 Sales Market Share by Type (2021-2026) Table 25. Global Galectin 3 Sales Market Share by Type (2027-2032) Table 26. Global Galectin 3 Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Galectin 3 Revenue by Type (2021-2026) & (k units) Table 28. Global Galectin 3 Revenue by Type (2027-2032) & (k units) Table 29. Global Galectin 3 Revenue Market Share by Type (2021-2026) Table 30. Global Galectin 3 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Metastatic Melanoma Table 32. Major Manufacturers of Portal Hypertension Table 33. Major Manufacturers of Liver Cirrhosis Table 34. Major Manufacturers of Others Table 35. Global Galectin 3 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Galectin 3 Sales by Application (2021-2026) & (k units) Table 37. Global Galectin 3 Sales by Application (2027-2032) & (k units) Table 38. Global Galectin 3 Sales Market Share by Application (2021-2026) Table 39. Global Galectin 3 Sales Market Share by Application (2027-2032) Table 40. Global Galectin 3 Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Galectin 3 Revenue by Application (2021-2026) & (k units) Table 42. Global Galectin 3 Revenue by Application (2027-2032) & (k units) Table 43. Global Galectin 3 Revenue Market Share by Application (2021-2026) Table 44. Global Galectin 3 Revenue Market Share by Application (2027-2032) Table 45. Global Galectin 3 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Galectin 3 Sales by Region (2021-2026) & (k units) Table 47. Global Galectin 3 Sales Market Share by Region (2021-2026) Table 48. Global Galectin 3 Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Galectin 3 Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Galectin 3 Sales by Country (2021-2026) & (k units) Table 52. North America Galectin 3 Sales by Country (2027-2032) & (k units) Table 53. Europe Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Galectin 3 Sales by Country (2021-2026) & (k units) Table 55. Europe Galectin 3 Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Galectin 3 Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Galectin 3 Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Galectin 3 Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Galectin 3 Sales by Country (2027-2032) & (k units) Table 62. Global Galectin 3 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Galectin 3 Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Galectin 3 Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Galectin 3 Revenue Market Share by Region (2021-2026) Table 66. Global Galectin 3 Revenue Market Share by Region (2027-2032) Table 67. MandalMed Inc Company Information Table 68. MandalMed Inc Business Overview Table 69. MandalMed Inc Galectin 3 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. MandalMed Inc Galectin 3 Product Portfolio Table 71. MandalMed Inc Recent Development Table 72. iTeos Therapeutics SA Company Information Table 73. iTeos Therapeutics SA Business Overview Table 74. iTeos Therapeutics SA Galectin 3 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. iTeos Therapeutics SA Galectin 3 Product Portfolio Table 76. iTeos Therapeutics SA Recent Development Table 77. GlycoMimetics Inc Company Information Table 78. GlycoMimetics Inc Business Overview Table 79. GlycoMimetics Inc Galectin 3 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlycoMimetics Inc Galectin 3 Product Portfolio Table 81. GlycoMimetics Inc Recent Development Table 82. Galectin Therapeutics Inc Company Information Table 83. Galectin Therapeutics Inc Business Overview Table 84. Galectin Therapeutics Inc Galectin 3 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Galectin Therapeutics Inc Galectin 3 Product Portfolio Table 86. Galectin Therapeutics Inc Recent Development Table 87. Bristol-Myers Squibb Company Company Information Table 88. Bristol-Myers Squibb Company Business Overview Table 89. Bristol-Myers Squibb Company Galectin 3 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Bristol-Myers Squibb Company Galectin 3 Product Portfolio Table 91. Bristol-Myers Squibb Company Recent Development Table 92. Angion Biomedica Corp Company Information Table 93. Angion Biomedica Corp Business Overview Table 94. Angion Biomedica Corp Galectin 3 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Angion Biomedica Corp Galectin 3 Product Portfolio Table 96. Angion Biomedica Corp Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Galectin 3 Distributors List Table 100. Galectin 3 Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Galectin 3 Product Image Figure 2. Global Galectin 3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galectin 3 Market Size (2021-2032) & (US$ Million) Figure 4. Global Galectin 3 Sales (2021-2032) & (k units) Figure 5. Global Galectin 3 Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Galectin 3 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. KTI Image Figure 9. GRMD-03 Image Figure 10. GAL-300 Image Figure 11. ANG-4021 Image Figure 12. Others Image Figure 13. Global Galectin 3 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Galectin 3 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Galectin 3 Sales Market Share by Type (2021-2032) Figure 16. Global Galectin 3 Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Galectin 3 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Galectin 3 Revenue Market Share by Type (2021-2032) Figure 19. Metastatic Melanoma Image Figure 20. Portal Hypertension Image Figure 21. Liver Cirrhosis Image Figure 22. Others Image Figure 23. Global Galectin 3 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Galectin 3 Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Galectin 3 Sales Market Share by Application (2021-2032) Figure 26. Global Galectin 3 Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Galectin 3 Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Galectin 3 Revenue Market Share by Application (2021-2032) Figure 29. North America Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Galectin 3 Sales Market Share by Country (2021-2032) Figure 31. U.S. Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Galectin 3 Sales Market Share by Country (2021-2032) Figure 36. Germany Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Galectin 3 Sales Market Share by Country (2021-2032) Figure 43. China Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Galectin 3 Sales Market Share by Country (2021-2032) Figure 51. Brazil Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Galectin 3 Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Galectin 3 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Galectin 3 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Galectin 3 Revenue (2021-2032) & (US$ Million) Figure 62. North America Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Galectin 3 Revenue (2021-2032) & (US$ Million) Figure 64. Europe Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Galectin 3 Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Galectin 3 Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Galectin 3 Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Galectin 3 Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • KTI
  • GRMD-03
  • GAL-300
  • ANG-4021
  • Others
Applications
  • Metastatic Melanoma
  • Portal Hypertension
  • Liver Cirrhosis
  • Others
Companies covered
  • MandalMed Inc
  • iTeos Therapeutics SA
  • GlycoMimetics Inc
  • Galectin Therapeutics Inc
  • Bristol-Myers Squibb Company
  • Angion Biomedica Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Galectin 3 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Galectin 3 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Galectin 3 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Galectin 3 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Galectin 3 Market Dynamics
  1. 2.1 Galectin 3 Industry Trends
  2. 2.2 Galectin 3 Industry Drivers
  3. 2.3 Galectin 3 Industry Opportunities and Challenges
  4. 2.4 Galectin 3 Industry Restraints
3 Galectin 3 Market by Manufacturers
  1. 3.1 Global Galectin 3 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Galectin 3 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Galectin 3 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Galectin 3 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Galectin 3 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Galectin 3 Manufacturers, Product Type & Application
  7. 3.7 Global Galectin 3 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Galectin 3 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Galectin 3 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Galectin 3 Tier 1, Tier 2, and Tier 3
4 Galectin 3 Market by Type
  1. 4.1 Galectin 3 Type Introduction
  2. 4.1.1 KTI
  3. 4.1.2 GRMD-03
  4. 4.1.3 GAL-300
  5. 4.1.4 ANG-4021
  6. 4.1.5 Others
  7. 4.2 Global Galectin 3 Sales by Type
  8. 4.2.1 Global Galectin 3 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Galectin 3 Sales by Type (2021-2032)
  10. 4.2.3 Global Galectin 3 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Galectin 3 Revenue by Type
  12. 4.3.1 Global Galectin 3 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Galectin 3 Revenue by Type (2021-2032)
  14. 4.3.3 Global Galectin 3 Revenue Market Share by Type (2021-2032)
5 Galectin 3 Market by Application
  1. 5.1 Galectin 3 Application Introduction
  2. 5.1.1 Metastatic Melanoma
  3. 5.1.2 Portal Hypertension
  4. 5.1.3 Liver Cirrhosis
  5. 5.1.4 Others
  6. 5.2 Global Galectin 3 Sales by Application
  7. 5.2.1 Global Galectin 3 Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Galectin 3 Sales by Application (2021-2032)
  9. 5.2.3 Global Galectin 3 Sales Market Share by Application (2021-2032)
  10. 5.3 Global Galectin 3 Revenue by Application
  11. 5.3.1 Global Galectin 3 Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Galectin 3 Revenue by Application (2021-2032)
  13. 5.3.3 Global Galectin 3 Revenue Market Share by Application (2021-2032)
6 Global Galectin 3 Sales by Region
  1. 6.1 Global Galectin 3 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Galectin 3 Sales by Region (2021-2032)
  3. 6.2.1 Global Galectin 3 Sales by Region (2021-2026)
  4. 6.2.2 Global Galectin 3 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Galectin 3 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Galectin 3 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Galectin 3 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Galectin 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Galectin 3 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Galectin 3 Revenue by Region
  1. 7.1 Global Galectin 3 Revenue by Region
  2. 7.1.1 Global Galectin 3 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Galectin 3 Revenue by Region (2021-2026)
  4. 7.1.3 Global Galectin 3 Revenue by Region (2027-2032)
  5. 7.1.4 Global Galectin 3 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Galectin 3 Revenue (2021-2032)
  8. 7.2.2 North America Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Galectin 3 Revenue (2021-2032)
  11. 7.3.2 Europe Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Galectin 3 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Galectin 3 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Galectin 3 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 MandalMed Inc
  2. 8.1.1 MandalMed Inc Company Information
  3. 8.1.2 MandalMed Inc Business Overview
  4. 8.1.3 MandalMed Inc Galectin 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MandalMed Inc Galectin 3 Product Portfolio
  6. 8.1.5 MandalMed Inc Recent Developments
  7. 8.2 iTeos Therapeutics SA
  8. 8.2.1 iTeos Therapeutics SA Company Information
  9. 8.2.2 iTeos Therapeutics SA Business Overview
  10. 8.2.3 iTeos Therapeutics SA Galectin 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 iTeos Therapeutics SA Galectin 3 Product Portfolio
  12. 8.2.5 iTeos Therapeutics SA Recent Developments
  13. 8.3 GlycoMimetics Inc
  14. 8.3.1 GlycoMimetics Inc Company Information
  15. 8.3.2 GlycoMimetics Inc Business Overview
  16. 8.3.3 GlycoMimetics Inc Galectin 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlycoMimetics Inc Galectin 3 Product Portfolio
  18. 8.3.5 GlycoMimetics Inc Recent Developments
  19. 8.4 Galectin Therapeutics Inc
  20. 8.4.1 Galectin Therapeutics Inc Company Information
  21. 8.4.2 Galectin Therapeutics Inc Business Overview
  22. 8.4.3 Galectin Therapeutics Inc Galectin 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Galectin Therapeutics Inc Galectin 3 Product Portfolio
  24. 8.4.5 Galectin Therapeutics Inc Recent Developments
  25. 8.5 Bristol-Myers Squibb Company
  26. 8.5.1 Bristol-Myers Squibb Company Company Information
  27. 8.5.2 Bristol-Myers Squibb Company Business Overview
  28. 8.5.3 Bristol-Myers Squibb Company Galectin 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bristol-Myers Squibb Company Galectin 3 Product Portfolio
  30. 8.5.5 Bristol-Myers Squibb Company Recent Developments
  31. 8.6 Angion Biomedica Corp
  32. 8.6.1 Angion Biomedica Corp Company Information
  33. 8.6.2 Angion Biomedica Corp Business Overview
  34. 8.6.3 Angion Biomedica Corp Galectin 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Angion Biomedica Corp Galectin 3 Product Portfolio
  36. 8.6.5 Angion Biomedica Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Galectin 3 Value Chain Analysis
  2. 9.1.1 Galectin 3 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Galectin 3 Production Mode & Process
  6. 9.2 Galectin 3 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Galectin 3 Distributors
  9. 9.2.3 Galectin 3 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst